Drug Shortage Report for ADENOSINE INJECTION
Report ID | 145130 |
Drug Identification Number | 02267659 |
Brand name | ADENOSINE INJECTION |
Common or Proper name | Adenosine Injection 3 mg/mL SD Vial 2 mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | ADENOSINE |
Strength(s) | 3MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 2 mL Vial |
ATC code | C01EB |
ATC description | OTHER CARDIAC PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-09-10 |
Actual start date | |
Estimated end date | 2021-11-03 |
Actual end date | 2021-11-03 |
Shortage status | Resolved |
Updated date | 2021-11-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2021-11-04 | English | Compare |
v9 | 2021-11-03 | French | Compare |
v8 | 2021-11-03 | English | Compare |
v7 | 2021-10-29 | French | Compare |
v6 | 2021-10-29 | English | Compare |
v5 | 2021-10-01 | French | Compare |
v4 | 2021-10-01 | English | Compare |
v3 | 2021-09-11 | English | Compare |
v2 | 2021-09-02 | French | Compare |
v1 | 2021-09-02 | English | Compare |
Showing 1 to 10 of 10